SCHEMBL19869332

SCHEMBL19869332

Cc1ccc(S(=O)(=O)ON=C(c2cccc([N+](=O)[O-])c2)C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.49
ALDH1A1 P00352 6/20 0.49
KMT2A Q03164 3/20 0.49
NPC1 O15118 2/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
LMNA P02545 2/20 0.48
MCOLN3 Q8TDD5 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
GPR17 Q13304 3/20 0.46
CYP2C19 P33261 4/20 0.46
CYP1A2 P05177 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2D6 P10635 1/20 0.46
MEN1 O00255 2/20 0.45
POLB P06746 2/20 0.44
P2RY2 P41231 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28652373 0.85 ALDH1A1 (0.46) MAPTALDH1A1KMT2ANPC1HTT
SCHEMBL12984403 0.83 GAA (0.40) MAPTALDH1A1KMT2ANPC1RAB9A
SCHEMBL12984400 0.83 GAA (0.40) MAPTALDH1A1KMT2ANPC1RAB9A
SCHEMBL16063707 0.82 LMNA (0.42) MAPTALDH1A1KMT2AHTTRAB9A
SCHEMBL13259614 0.82 NPC1 (0.46) ALDH1A1KMT2ANPC1RAB9ALMNA
SCHEMBL13285389 0.82 NPC1 (0.46) ALDH1A1KMT2ANPC1RAB9ALMNA
SCHEMBL547034 0.77 MAPT (0.44) MAPTALDH1A1KMT2AHTTRAB9A
SCHEMBL547035 0.77 MAPT (0.44) MAPTALDH1A1KMT2AHTTRAB9A
SCHEMBL14472762 0.76 KMT2A (0.39) MAPTALDH1A1KMT2ANPC1HTT
SCHEMBL4903378 0.75 KMT2A (0.38) MAPTALDH1A1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400502-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME UNIV QUEENSLAND (AU) 2024-12-05 US disclosed
US-11845715-B2 2023-12-19 US disclosed
US-20220112159-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME UNIV QUEENSLAND (AU) 2022-04-14 US disclosed
US-20180044287-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME INFLAZOME LIMITED (IE) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220112159-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, PYCARD, IAPP MAPT 1672/4885ALDH1A1 3558/4885KMT2A 4072/4885
US-11845715-B2 NLRP3, PYCARD, NOD1 MAPT 1265/4885ALDH1A1 3407/4885KMT2A 4317/4885
US-20240400502-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, PYCARD, IAPP MAPT 1672/4885ALDH1A1 3558/4885KMT2A 4072/4885
US-20180044287-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, PYCARD, IAPP MAPT 1672/4885ALDH1A1 3558/4885KMT2A 4072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.